New Nitric Oxide Donor NCX 1443: Therapeutic Effects on Pulmonary Hypertension in the SAD Mouse Model of Sickle Cell Disease-Reference-Cited by-同舟云学术

New Nitric Oxide Donor NCX 1443: Therapeutic Effects on Pulmonary Hypertension in the SAD Mouse Model of Sickle Cell Disease

Published:2018-05 Issue:5 Volume:71 Page:283-292
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Abid Shariq,Kebe Kanny,Houssaïni Amal,Tomberli Françoise,Marcos Elisabeth,Bizard Emilie,Breau Marielle,Parpaleix Aurelien,Tissot Claire-Marie,Maitre Bernard,Lipskaia Larissa,Derumeaux Genevieve,Bastia Elena,Mekontso-Dessap Armand,Adnot Serge

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference30 articles.

1. Cellular and molecular pathobiology of pulmonary arterial hypertension;Humbert;J Am Coll Cardiol.,2004

2. Pulmonary hypertension in patients with sickle cell disease: a longitudinal study;Ataga;Br J Haematol.,2006

3. Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival;Castro;Blood.,2003

4. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease;Gladwin;N Engl J Med.,2004

5. Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway;Jison;Am J Respir Crit Care Med.,2003

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endothelial dysfunction in Sickle Cell Disease: Strategies for the treatment;Nitric Oxide;2024-08

2. NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE;Mediterranean Journal of Hematology and Infectious Diseases;2019-01-01